Drug firms want R&D sops to continue
The pharmaceuticals industry in India will have something to pass on to patients other than drugs in 2008. Prices of more than 7,000 drugs classified as “essential medicines” are likely to witness a sharp fall after the forthcoming budget.
A section of the industry had also called on the government to extend the tax benefits available for research and development to pharmaceutical companies by five more years, a top industry executive said.
Yet others are demanding halving the 16 per cent excise duty levied on drug companies that are not set up in designated tax-free zones in states such as Himachal Pradesh and Sikkim.
Numbers though, speak of a bright 2008 ahead. IMS 2008 Global Pharmaceutical Market Forecast, a worldwide study by IMS-ORG, a global research organisation, says that India and other emerging markets will experience growth of 12-13 per cent to reach $85-90 billion (Rs 3,.4 to 3.5 lakh crore), driven by greater access to generics and innovative new medicines as primary care improves and becomes more available in rural areas, and as more people take out private health insurance.
“For the first time, the seven largest markets will contribute just half of overall pharmaceuticals growth, while seven emerging markets will contribute nearly 25 per cent of growth worldwide," says the study.
“Our only demand is to extend the tax benefits made available to research and development activities by five more years,” said DG Shah, director-general, Indian Pharmaceuticals Alliance, an industry body for generic pharmaceutical companies.
Contrary to previous years, the Indian domestic medicine market is emerging as a high growth area for pharmaceutical companies. According to IMS-ORG, the rural segment and metros show encouraging growth of 21 per cent and 16 per cent, respectively.
Enter your email to get our daily newsletter in your inbox
- The 15th Finance Commission has recommended that states be given 41 per cent of the divisible tax pool of the Centre during the period 2021-22 to 2025-26, which is at the same level as was recommended by the 14th Finance Commission.
- Here’s a list of some of the tasks which need to be performed by taxpayers before March 31
- In an interaction with members of the Indian Women’s Press Corps (IWPC), Sitharaman said that consumer sentiment about the tax burden on auto fuel was understandable.
- Nearly 1.1 million vaccine doses were administered to people above the age of 60 and those in the 45-59 age group till Thursday.
- Mohapatra said the idea came during Modi’s meeting with Marriott International president and chief executive Arne Sorenson, who complained about the complex regulations in starting and running a hotel in India.
- ICICI Bank’s move comes days after rival lenders such as State Bank of India (SBI), Kotak Mahindra Bank and Housing Development Finance Corp. Ltd cut their home loan rates.
- These votes will have to be disclosed to unit holders under existing regulations. Voting will be at the MF level (rather than scheme level).
- Supply of vehicles from Maruti Suzuki India Ltd—as part of the alliance with Suzuki Motor Corp—has helped Toyota increase its domestic market share in the premium hatchback and entry-level SUV segment, where it was not present before.
- The top three states by GVA were Maharashtra, Gujarat, and Tamil Nadu. They had a share of 41% in the total GVA. Rural India added nearly as much GVA (49%) as urban India (51%).
- Using average consumption shares to calculate the burden of an indirect tax has a problem.